Table 5.
Laboratory parameters
| Variables | N | Values |
|---|---|---|
| LVEF (%) | ||
| Increased LVEF (>75%) | 220 | 13 (5.9) |
| Normal LVEF (50%–75%) | 53 (24.1) | |
| Moderately reduced (30%–49%) | 34 (15.5) | |
| Severely reduced (<30%) | 24 (10.9) | |
| Unknown | 96 (43.6) | |
| A1C (%) | ||
| <8.0% | 220 | 25 (56.8) |
| ≥8.0% | 95 (43.2) | |
| FBG (mmol/L) | 195 | 10.2 (5.0) |
| Lipid profile | ||
| Total cholesterol (mmol/L) | 211 | 4.4 (1.3) |
| HDL (mmol/L) | 211 | 1.0 (0.8–1.3) |
| LDL (mmol/L) | 210 | 2.4 (1.8–3.1) |
| Triglyceride (mmol/L) | 210 | 1.6 (1.8–3.1) |
| Blood pressure (BP) | ||
| SBP (mmHg) | 142 | 144 (25.3) |
| DBP (mmHg) | 142 | 74 (66.8–84.0) |
| Cardiac biomarker | ||
| CK (U/L) | 199 | 121.0 (76.0–243.0) |
| CK-MB (U/L) | 196 | 2.0 (1.0–4.0) |
| TnI (ng/L) | 154 | 0.1 (0.0–0.9) |
Notes: Values presented as mean (SD) if normally distributed or median (interquartile range) if skewed for continuous data; n (%) for categorical data.
Abbreviations: LVEF, left ventricular ejection fraction; A1C, glycated hemoglobin; FBG, fasting blood glucose; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood pressure; DBP, diastolic blood pressure; CK, creatine kinase; CK-MB, creatine kinase-MB; TnI, Troponin-I.